Supply of epilepsy drug disrupted until May


Facebook
Twitter
LinkedIn

By Beth Kennedy
Editor-in-chief

10 Jan 2020

The manufacturer Accord will be out of stock of the anti-epileptic drug Phenytoin Sodium NRIM 100mg capsules until ‘early May’.

The Department of Health and Social Care issued a supply disruption alert today (10 January), which contains advice on how to manage patients affected by the shortage.

The Pharmaceutical Services Negotiating Committee noted that as phenytoin is a category 1 anti-epileptic drug, it is recommended that patients are kept of a specific manufacturer’s product.

The negotiator noted that an alternative phenytoin sodium 100mg capsules manufactured by Flynn Pharma is available but warned that ‘switching to an alternative formulation requires monitoring and may also require specialist support, advice or referral’.


Want news like this straight to your inbox?


Latest News

CPCS: How to make the most of your NHS 111 referrals
The very nature of the community pharmacist consultation service (CPCS) is unpredictable, with the distribution...
Black and Asian patients prescribed dementia drugs differently to white patients
Black and Asian patients with dementia in the UK receive a worse quality of care...
HIV cases reduce by over 70% among UK gay and bisexual men in six years
The transmission of HIV has fallen by more than 70% in six years among gay...